OmniActive Health Technologies (OmniActive), a global leader in the consumer wellness industry through innovative science and natural ingredients, today announced the official launch of Fenavari, its ...

Managing your weight in middle age can be remarkably frustrating, especially when habits that used to work suddenly stop ...

"The study builds on the Phase 1b trial, providing consistent clinical evidence that CD122 blockade can protect against gluten-induced intestinal damage and prevent emergence of patient symptoms, even ...

Filament has signed an agreement to supply PEX010 to Epsylon ASBL for what the Company believes will be the first program in ...

Veeva Systems VEEV recently expanded its partnership with IQVIA IQV, with the latter selecting additional Veeva clinical ...

Start with the money. Lenders put $237.7M behind a Novartis-anchored manufacturing campus in Morrisville, Liquidia agreed to ...

Back and shoulder surgery is often worse than useless Many surgical interventions are little better than placebo Before ...

IQVIA and Veeva Systems announced on October 13, 2026 an expansion of their partnership. IQVIA has selected Veeva CTMS, eTMF, ...

Hepion Pharmaceuticals completes the Gravitas Life Sciences acquisition, creating a three-program portfolio across therapeutics and diagnostics.

Registered Trademark Reinforces UpRight Science’s Commitment to Making Balance Measurement a Routine Part of Conversations between Patients and Physicians. West Palm Beach, Fla., October 14, 2026 ...

The ultimate goal when adopting AI tools should be to reduce friction while keeping clinical and operational judgment at the ...

Anavex Life Sciences will proceed with a clinical study of a new drug to treat the genetic disorder Fragile X syndrome after getting clearance from U.S. regulators. The company said the Food and Drug ...